Products for Research Use Only
RegisterLogin

(R) -ND-336

CAT: 0804-HY-124373ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-124373ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
(R) -ND-336 is a potent and selective MMP-9 inhibitor with a Ki of 19 nM. (R) -ND-336 inhibits MMP-2 (Ki=127 nM) and MMP-14 (Ki=119 nM) . (R) -ND-336 has the potential for diabetic foot ulcers (DFUs) research[1].
CAS Number
2252493-33-5
UNSPSC
12352005
Target
MMP
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/r-nd-336.html
Solubility
10 mM in DMSO
Smiles
NCC1=CC=C(OC2=CC=C(C=C2)S(C[C@@H]3SC3)(=O)=O)C=C1.Cl
Molecular Formula
C16H18ClNO3S2
Molecular Weight
371.90
References & Citations
[1]Trung T Nguyen, et al. Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing. J Med Chem. 2018 Oct 11;61 (19) :8825-8837.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MMP-14; MMP-2; MMP-9

Related Products

CatalogName
HY-124373-01ND-336
HY-127108ND-654
HY-101842-01ND-646
HY-117622ND-2110
HY-120041ND-2158
HY-124341ND-378
HY-107055-01RTI 336
HY-155107-01ND-011992
HY-156683-01CHK-336
HY-121852-01SCH 336

Alternative Products

CatalogName
GTR19196963-01ND-336
T61491-01(R) -ND-336
MBS5804195(R)-ND-336
A135334MOR101 Biosimilar (Monoclonal, Fab-nd-nd)
A135120Pexelizumab Biosimilar (Monoclonal, scFv-nd-nd)
406951ND-646
T77615-01ND-011992
B2248-5ND-630
MBS5777838ND-2110
M11847-01ND-654

Popular Products